Building better readers should involve more than teaching the core components of early literacy—these five strategies are grounded in science and tested by expert educators.
Should you have feedback on this article, please complete the fields below. Please indicate if your feedback is in the form of a letter to the editor that you wish to have published. If so, please be ...
The Education Secretary will set out the core tenets of the Government’s forthcoming Schools White Paper in a speech to a conference. The Education Secretary will set an ambition for 90% of pupils to ...
You write that “California Learns From Mississippi” (Review & Outlook, Sept. 27) on phonics, but I fear you give too much credit to Golden State legislators. Assembly Bill 2222, proposed in 2024, ...
Proceeds Fund the Clinical Development of TORL-1-23, Currently in a Registrational Phase 2 Study for Claudin 6 Positive (CLDN6+) Platinum-Resistant Ovarian Cancer and in Phase 1 for other CLDN6+ ...
AUSTIN (KXAN) — The Congress Avenue Urban Design Initiative (CAUDI) is preparing for the first construction phase to redesign Congress Avenue between Cesar Chavez and 7th Streets in downtown Austin.
-Clinical data to date supports a potentially transformational approach to treating autoimmune diseases with an off-the-shelf, one-time therapy- -As of the August 31, 2025 data cut-off date, all seven ...
615 River Road, a $1 billion, 1,200-apartment mixed-use development located along New Jersey’s Gold Coast, has been awarded $255 million in construction financing for its first phase, a 25-story, ...
Capsida Biotherapeutics has paused a gene therapy trial after the first patient died. The biotech, which began the phase 1/2 study in July, took the action to give it time to determine the “root cause ...
LAWRENCE, Kan. — Just more than 33 months after the initial vision was announced, the reimagined David Booth Kansas Memorial Stadium is set to officially reopen this Saturday when the Kansas Jayhawks ...
GLIX1, a first-in-class small molecule, targets DNA repair vulnerabilities, offering potential glioblastoma therapy. Hemispherian will initiate a phase 1 trial to evaluate GLIX1's safety, tolerability ...